Prognostic value of methylation status of RASSF1A gene as an independent factor of non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 13, Issue 4, 2010, Pages 311-316

  Zhang, Hui ^a   Zhang, Shucai ^a   Zhang, Zongde ^a   Jia, Hongyan ^a   Gu, Shuxiang ^a   Zhao, Dan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Lung neoplasms; Methylation; Prognosis

Indexed keywords

RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; METHYLATION; PROGNOSIS; PROMOTER REGION; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 77951548859     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2010.04.08     Document Type: Article

References (19)

1. Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat Genet, 2000, 25(3): 315-319.
2. Qin YP, Wang LD, Chang ZW, et al. RASSF1A methylation detection in esophageal cancer tissue and matched peripheral blood from the same patients. Chin J Cancer Prev Treat, 2009, 16(5): 359-361.
3. Dong XM, Liu YH, Pan WR. The clinical research on promoter methylation of the RASSF1A in glioma. Chin Clini Oncol, 2008, 13(6): 499-502.
4. Tsou JA, Shen LYC, Siegmund KD, et al. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer, 2005, 47(2): 193-204.
5. Lin Q, Geng J, Ma K, et al. RASSF1A , APC, ESR1, ABCB1 and HOXC9, but p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. J Cancer Res Clin Oncol, 2009, 135(12): 1675-1684.
6. De Jong WK, Verpooten GF, Kramer H, et al. Promoter methylation primarly occurs in tumor cells of patients with non-small cell lung cancer. Anticancer Res, 2009, 29(1): 363-369.
7. Divine KK, Pulling LC, Marron-Terada PG, et al. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Int J Cancer, 2005, 114(3): 400-405.
8. Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer, 2003, 103(2): 153-160.
9. Kim DH, Kim JS, Ji YI, et al. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res, 2003, 63(13): 3743-3746.
10. Marsit CJ, Kim DH, Liu M, et al. Hypermethylation of RASSF1A and BLU tumour suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer, 2005, 114(2): 219-223.
11. Tomizawa Y, Kohno T, Kondo H, et al. Clinicopathological signficance of epigentic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res, 2002, 8(7): 2362-2368.
12. Endoh H, Yatabe Y, Shi mizu S, et al. RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication. Int J Cancer, 2003, 106(1): 45-51.
13. Choei N, Son DS, Song I, et al. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer. Int J Cancer, 2005, 115(4): 575-581.
14. Song MS, Chang JS, Song SJ, et al. The centrosomal protein RAS association domain family protein 1A (RASSF1A)-binding protein 1 regulates mitotic progression by recruiting RASSF1A to spindle poles. J Biol Chem, 2005, 280(5): 3920-3927.
15. Song SJ, Song MS, Kim SJ, et al. Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity. Cancer Res, 2009, 69(6): 2314-12313
16. Thaler S, Hahnel PS, Schad A, et al. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res, 2009, 69(5): 1748-1757.
17. Jung H OH, Lee K, Song S J, et al. Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res, 2006, 66(5): 2562-2569.
18. van der Weyden L, Tachibana KK, Gonzalez, et al. The RASSF1A isoform of RASSF1A promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol, 2005, 25(18): 8356-8367.
19. Whang YM, Park KH, Jung HY, et al. Microtubule-damaging agents enhance RASSF1A-induced cell in lung cancer cell lines. Cancer, 2009, 115(6): 1253-1266.